Literature DB >> 2532157

Cell surface sialic acid affects immunoglobulin binding to macrophages.

W Gorczyca1, Z Wieczorek, J Lisowski.   

Abstract

We demonstrate that guinea pig peritoneal macrophages pretreated with neuraminidase from Vibrio cholerae bind more 125I-IgG than non-treated cells. Estimation of binding constants (Ka and Bmax) shows that the elevation of binding is the result of an increase in affinity and not in the number of receptors for IgG. The change of affinity is proportional to amounts of sialic acid liberated from the cells by increasing doses of neuraminidase. It is also shown that affinity of interactions of IgG with the macrophage receptor is pH dependent. These results indicate that electrostatic forces are important for IgG binding to the macrophage Fc gamma R. The IgG-Fc gamma R interaction can be modulated by changing the degree of sialylation of the macrophage surface glycoconjugates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2532157     DOI: 10.1016/0014-5793(89)81504-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Globally profiling sialylation status of macrophages upon statin treatment.

Authors:  Dan Wang; Huan Nie; Evgeny Ozhegov; Lin Wang; Aimin Zhou; Yu Li; Xue-Long Sun
Journal:  Glycobiology       Date:  2015-06-01       Impact factor: 4.313

2.  Sialyltransferase and Neuraminidase Levels/Ratios and Sialic Acid Levels in Peripheral Blood B Cells Correlate with Measures of Disease Activity in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Pilot Study.

Authors:  Lieh-Bang Liou; Che-Ching Huang
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

3.  Neuraminidase Inhibitor Zanamivir Ameliorates Collagen-Induced Arthritis.

Authors:  Bettina Sehnert; Juliane Mietz; Rita Rzepka; Stefanie Buchholz; Andrea Maul-Pavicic; Sandra Schaffer; Falk Nimmerjahn; Reinhard E Voll
Journal:  Int J Mol Sci       Date:  2021-01-31       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.